These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9746215)

  • 1. The salubrious effect of tamoxifen [correction of Tamaxifen] on serum marker enzymes, glycoproteins, and lysosomal enzymes level in breast cancer woman.
    Thangaraju M; Rameshbabu J; Vasavi H; Ilanchezhian S; Vinitha R; Sachdanandam P
    Mol Cell Biochem; 1998 Aug; 185(1-2):85-94. PubMed ID: 9746215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Coenzyme Q(10), Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles.
    Yuvaraj S; Premkumar VG; Shanthi P; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Breast Cancer Res Treat; 2009 Mar; 114(2):377-84. PubMed ID: 18427979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.
    Decensi A; Robertson C; Viale G; Pigatto F; Johansson H; Kisanga ER; Veronesi P; Torrisi R; Cazzaniga M; Mora S; Sandri MT; Pelosi G; Luini A; Goldhirsch A; Lien EA; Veronesi U
    J Natl Cancer Inst; 2003 Jun; 95(11):779-90. PubMed ID: 12783932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer.
    Wasan KM; Ramaswamy M; Haley J; Dunn BP
    J Pharm Sci; 1997 Jul; 86(7):876-9. PubMed ID: 9232532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
    Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal enzymes of neutrophils in women with breast cancer.
    Blicharski J; Lisiewicz J; Moszczyński P
    Folia Histochem Cytochem (Krakow); 1983; 21(3-4):195-201. PubMed ID: 6667909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serum hydroxyvitamin D levels of breast cancer patients during tamoxifen treatment or chemotherapy in premenopausal breast cancer patients.
    Kim HJ; Koh BS; Yu JH; Lee JW; Son BH; Kim SB; Ahn SH
    Eur J Cancer; 2014 May; 50(8):1403-11. PubMed ID: 24703104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tamoxifen, toremifene and chloroquine on the lysosomal enzymes in cultured retinal pigment epithelial cells.
    Toimela T; Salminen L; Tähti H
    Pharmacol Toxicol; 1998 Dec; 83(6):246-51. PubMed ID: 9868742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of radiation on serum glycoproteins and glycosidases in patients with cervical carcinoma.
    Bhuvarahamurthy V; Balasubramanian N; Vijayakumar S; Govindasamy S
    Int J Gynaecol Obstet; 1995 Jan; 48(1):49-54. PubMed ID: 7698383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of tamoxifen treatment on serum cholesterol fractions in breast cancer women.
    Dziewulska-Bokiniec A; Wojtacki J; Skokowski J; Kortas B
    Neoplasma; 1994; 41(1):13-6. PubMed ID: 8202188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study.
    Kristensen B; Ejlertsen B; Dalgaard P; Larsen L; Holmegaard SN; Transbøl I; Mouridsen HT
    J Clin Oncol; 1994 May; 12(5):992-7. PubMed ID: 8164053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.
    Ilanchezhian S; Thangaraju M; Sachdanandam P
    Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Cancer Chemother Pharmacol; 2008 May; 61(6):933-41. PubMed ID: 17668211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer.
    Zidan J; Keidar Z; Basher W; Israel O
    Med Oncol; 2004; 21(2):117-21. PubMed ID: 15299183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early effects of adjuvant tamoxifen therapy on serum hormones, proteins and lipids.
    Kailajärvi M; Ahokoski O; Virtanen A; Salminen E; Irjala K
    Anticancer Res; 2000; 20(2B):1323-7. PubMed ID: 10810443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycohydrolases and lysosomal stability in adjuvant induced arthritis.
    Arumugham R; Bose SM
    Ital J Biochem; 1980; 29(1):27-40. PubMed ID: 7380646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tamoxifen on the serum levels of oestrogens and adrenocortical steroids in postmenopausal breast cancer patients.
    Wilking N; Carlström K; Sköldefors H; Theve NO; Wallgren A
    Acta Chir Scand; 1982; 148(4):345-9. PubMed ID: 6215811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer.
    Karlsson E; Veenstra C; Emin S; Dutta C; Pérez-Tenorio G; Nordenskjöld B; Fornander T; Stål O
    Breast Cancer Res Treat; 2015 Aug; 153(1):31-40. PubMed ID: 26208487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane.
    Gonnelli S; Cadirni A; Caffarelli C; Petrioli R; Montagnani A; Franci MB; Lucani B; Francini G; Nuti R
    Bone; 2007 Jan; 40(1):205-10. PubMed ID: 16904960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.